Phase 2 Metastatic NSCLC - Non-Small Cell Lung Cancer Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Metastatic NSCLC - Non-Small Cell Lung Cancer

Swiss Cancer Institute156 enrolled17 locationsNCT07020065

Recruiting

Phase 2

Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.

Metastatic NSCLC - Non-Small Cell Lung Cancer

Fondazione Ricerca Traslazionale33 enrolled1 locationNCT07392658